Wednesday, November 13, 2019
 

SMART MedTech at SEMICON Europa

10:00 Welcome
  Cassandra Melvin, SEMI Europe

Cassandra Melvin

SEMI Europe

 

Global Perspectives in Health Care

Chair Cassandra Melvin
10:05 Global Health Care Challenges and Trends
  Benjamin Wiegand, Global Head World Without Disease Accelerator, Janssen Pharmaceutical Companies of Johnson & Johnson
10:30
Perspectives on Healthcare, the Medtech Industry, and Digital
  Michael Strübin, Director Digital Health, MedTech Europe
Perspectives on Healthcare, the Medtech Industry, and Digital
Michael Strübin

Michael Strübin
Director Digital Health
MedTech Europe

Michael Strübin

Abstract
Healthcare represents one of the biggest sectors in advanced industrialised countries (the OECD average in 2017 was 8.8 percent of GDP), yet as a market it may be one of the most complicated to access: fragmentation, the strong role of the public sector, the high level of regulation, the often competing interests of powerful stakeholders, and other factors make life difficult for industry. New regulations for medical devices and in vitro diagnostic devices, enacted in 2016, will come into force in the coming years. And advances in technologies, especially in digital, have the potential to change and upend the doctor-patient relationship. These and more developments will be covered in this keynote from MedTech Europe, the largest trade association for the medtech industries in Europe.

Biography
Michael Strübin joined MedTech Europe as Digital Health Director in 2018 to help develop the industry’s voice in the digital health field and to represent MedTech Europe’s members vis-à-vis digital health policymakers and stakeholders.Prior to MedTech Europe, Michael ran the European operations of the Continua Health Alliance (renamed Personal Connected Health Alliance in 2014), an international association of health and technology companies, governments and research organisations to advance personal connected health. Between 2006 to 2008, Michael was the first European Director of the Health Information and Management Systems Society (HIMSS). Michael studied political science and humanities in Germany and the United States, and worked in international development and philanthropy. Since 2003 he has been based in Brussels.

10:55 Europe's Health Care Plan
  TBD
11:20 Bringing the Power of Chip Technology to Healthcare
  Herlien Declerk, Business Development Manager, Life Sciences, imec
11:45 Bridging the Gap from Semiconductors to Medical Technologies
  TBD
 

The Digitization of Preventive Health Care

Chair Herlien Declerck
12:10 Opening
12:15 Challenge opener
  imec
12:40 Can Wearables Help Prevent the Silent Killer, Blood Pressure?
  Sudhir Mulpuru, Director of Product Management Industrial and Healthcare Business Unit, Maxim Integrated
13:05
Sensors to Enable Consumer Health Applications
  Filip Frederix, Senior Marketing Manager Smart Medical Devices, ams
Sensors to Enable Consumer Health Applications
Filip Frederix

Filip Frederix
Senior Marketing Manager Smart Medical Devices
ams

Filip Frederix

Abstract
Healthcare costs are rising due to an aging population and with decreasing funds from governments and insurance companies, our society needs to implement efficient healthcare solutions and more critically, pay more attention to prevention, early diagnosis and remote monitoring. This explains the recent rise of consumer health solutions. In this abstract, we will discuss the requirements related to the sensor technologies in medical-grade devices. We will demonstrate various technology approach options in the field of point-of-care (POC) diagnostics and portable consumer health devices. To take full advantage of preventative care, it is important that people are able to frequently monitor their health status. Research shows that monitoring tools must be easy to use, non-evasive and connected, with the ultimate goal is for these tools to be used at home or at the GP´s office. POC testing or rapid tests have the potential to solve these challenges. A relevant example is the commonly used home pregnancy tests, which are based on the lateral flow testing principle. At ams, we developed an electronic/optical readout for these tests to boost the sensitivity and enable multiplex capabilities. We will highlight a first prototype of this technology and its performance. We will also present the VivaVita, which is a result of a corporation between Joysys and ams. We will explain the working principle, the specifications and the applications. The VivaVita device allows generating medical quality data at a consumer level or outside a hospital setting. The VivaVita measures heart rate variability, ECG and blood pressure with a small, portable and fully integrated device. It is operated in a consumer friendly way, it is cost-effective and enables wireless data transfer and wireless charging. The core of the device is the AS7026 module, which is a low power, fully integrated optical module that allows for photo plethysmography (PPG) measurements in a reliable way.

Biography
Filip Frederix has worked for more than 20 years in the field of nanotechnology for healthcare products and is author of several publications and patents. Filip joined ams in October 2017 to spearhead the ams marketing efforts for Smart Medical Devices within the Imagine New Sensor Division. With a proven track-record in starting new business opportunities, Filip´s background includes working as an independent consultant supporting life sciences startups with capital raising and their business strategy. The largest part of his career was spent at NXP as a program director and new business development manager for healthcare products. In 2004 Filip won the prestigious DSM award, where he continued to work on emerging business projects at DSM in the Netherlands. While working as a post-doctoral researcher at IMEC, he earned his PhD degree in Chemistry from the University of Leuven in 2004. He serves as part-time professor at the University of Hasselt (since 2013).

13:30 Monitoring Sleep to Prevent Health Issues and Costs
  Tapan Shah, Principal Member of Technical Staff Industrial and Healthcare Business Unit, Maxim Integrated
13:55

Break

 

Revolutionizing Health Care with Personalized Medicine

Chair Henry Leistner
14:15 Challenge opener
  Jerome Mouly, Senior Analyst & Business Developer, Yole
14:40 Drug Delivery Applications
  TBD
15:05 Companion Diagnostics
  TBD
15:30 End user | Personalized Medicine
  TBD
16:00

Technology Demo Zone & Networking

17:00

End

Thursday, November 14, 2019
 

The Digital Patient: The Future of Artificial Organs & Human Avatars

Chair Patrick Boisseau, Director EU R&I Partnerships Policies, MedTech Europe
Patrick Boisseau

Patrick Boisseau
Director EU R&I Partnerships Policies
MedTech Europe

Patrick Boisseau

Biography
Patrick Boisseau is the Director, EU Research & Innovation Partnership Policies at MedTech Europe, the EU association of medtech and in vitro diagnostics industries, based in Brussels (Belgium). He is a core member of the Inter Association Task Force setting up the future Public Private Partnership on Health Innovation under Horizon Europe.Until recently Patrick was VP Europe at CEATech Healthcare Institute, based in Grenoble (France). He managed a significant number of EU collaborative projects, research infrastructures, coordination actions and networks of excellence for the past 20 years. His scientific and technical expertise focuses on innovative medical technologies.

10:00 Day Two Opening
  Patrick Boisseau, Director EU Research & Innovation Partnerships Policies, MedTech Europe
10:05 Human Avatars, the Next Paradigm in Healthcare
  Adrian Ionescu, Professor at EPFL Lausanne
10:30 Organ-on-Chip
  TBD
10:55 The Digital Patient: Will We One Day Have our Own Health Avatars?
  Philips Ger Janssen, Department Head Multiphysics & Optics and Program Manager Patient Digital Twin, Philips
11:20 The Future of Personalized Treatment
  Dr. Franz Laermer, Project Director, Robert Bosch GmbH
11:45 The Clinician’s Point of View
  Prof. Anthony Mathur, Director of Interventional Cardiology, Bart's Heart Centre
12:10

Break

12:40 Panel discussion

Panel: Key Drivers Transforming Healthcare: AI, Big Data and Cyber Security

Panelists
 

Pioneering Research in Medical Technologies

Chair Anne Van den Bosch
13:25 CMOS Compatible SiN Technology Platform for Life Science Applications
  Process Integration Engineer, Life Science Process Integration Group, PhD candidate in Physics, KU Leuven
13:45
Microfluidic, CMOS Microelectrode Array-based Organ-on-chip System: a Platform for Personalized Medicine
  Thomas Pauwelyn, Postdoctoral Researcher, imec
Microfluidic, CMOS Microelectrode Array-based Organ-on-chip System: a Platform for Personalized Medicine
Thomas Pauwelyn

Thomas Pauwelyn
Postdoctoral Researcher
imec

Thomas Pauwelyn

Abstract
Healthcare has traditionally focused on one-size fits-all medication to treat populations instead of tailoring treatments to individual patients. Recent advances in stem cell technology, allow researchers to create models of diseases or individual patients for personalized medicine. Although organ-on-chip devices expose these models to a more physiological cellular environment, these devices face significant challenges including assay throughput, signal quality, and scalability of production.To address these challenges, imec developed a 16k CMOS-based microelectrode array with 16 independent, microfluidic chambers. This platform offers both scalability in fabrication and assay throughput. Further micropatterning of the surface allows for a structured growth that better resembles a specific organ. By combining these devices with patient-specific cell models, these platform shows great potential for cardiac, neuronal, and oncological applications in the field of personalized medicine.

Biography
Dr Thomas Pauwelyn has studied at KU Leuven, Belgium, since 2008. He earned his BSc in Bioscience Engineering specializing in Catalytic Technologies in 2011 and a Master’s in Nanoscience and Nanotechnology with the Bioscience Engineering option in 2013. He then received an IWT fellowship to do a PhD at KU Leuven and imec’s Life Science Technologies group, which finished in 2018.Thomas is currently working as a post-doctoral researcher with an Innovation Mandate grant from VLAIO, investigating strategies to valorize the results from his research. Thomas’s research focuses on developing novel organ-on-chip systems for predictive toxicology and drug development. He is also investigating how organ-on-chip devices may help stratify patients and help enable personalized medicine.

 

MedTech Startup Challenge

Chair Michael Kaiser
14:05

Keynote

 
Smart Investments in Health
  Tom Vanhoutte, Partner, imec.xpand
14:20

Keynote

 
TBD
14:35

Keynote

 
TBD
14:50

Keynote

 
TBD
  Soukaina Adnane, Co-Founder & CCO at Onera Health
15:05

Keynote

 
TBD
15:20

Keynote

 
TBD
15:35

Keynote

 
TBD
15:50

Keynote

 
Closing by Session Chair
  Michael Kaiser, Managing Director, Smart Systems Hub GmbH